Executive Leadership

CSOFT’s executive team is located in our Boston headquarters, as well as various locations across North America, Europe, and Asia, providing global support for your business’s growth in any region or country. We firmly believe that a strong executive team is critical for the growth and success of any organization, and we take pride in having the top team in the localization industry. Our executive team offers round-the-clock, year-round coverage and support to meet all of your business growth requirements.

Shunee Yee

Founder & CEO, CSOFT International

Shunee Yee is a globally recognized entrepreneur and visionary leader in language technology, AI-enabled content systems, and cross-cultural communication. As Founder and CEO of CSOFT International, she has spent more than 25 years building a global enterprise that enables organizations to create, manage, and deliver multilingual content at scale across life sciences, technology, and other regulated industries.

Under her leadership, CSOFT has become a trusted partner to global enterprises, supporting complex, high-stakes content across more than 250 languages. The company delivers end-to-end solutions spanning software localization, technical documentation, regulatory submissions, clinical content, and customer communications. Shunee has consistently driven innovation in how global content is produced and governed, advancing approaches that combine AI, domain expertise, and structured validation to meet increasing demands for speed, accuracy, and compliance.

Building on this foundation, Shunee recently launched Sesen, an AI-driven governance platform designed for global regulated content in life sciences. Sesen serves as an operating layer for managing multilingual content across its full lifecycle, enabling pharmaceutical, biotech, CRO, and medical device organizations to produce certified, compliant, and submission-ready communications across 150+ languages. At the core of the platform is SesenGPT, a domain-trained AI capability purpose-built for regulated content, integrated with expert human oversight and structured validation to support quality, traceability, and regulatory alignment.

Shunee has been recognized by Fortune as one of the “Top 10 Most Powerful Women Entrepreneurs” and by CNN Money as one of the “Top 25 Innovation Disruptors.” She is known for scaling global businesses while leading digital transformation and helping organizations navigate the shift toward AI-enabled content operations.

She currently serves on the Board of Directors of the Joslin Diabetes Center, affiliated with Harvard Medical School and part of Beth Israel Lahey Health, and is a member of the International Women’s Forum (Massachusetts Chapter). She is also a committee member of the Nutrition Roundtable at the Harvard T.H. Chan School of Public Health.

Diego Di Leva

Vice President, Global Operations & Strategic Partnership

Originally from Italy, Diego Di Leva is the VP of Global Language Resources. In this role, Diego leads teams responsible for executing end-to-end project management and supply chain strategy.

He joined CSOFT as an Italian QA Specialist/Translator, position that he covered for five years after which he has started to cover more managerial and operational roles. Prior to joining CSOFT, Diego worked as a Tech Consultant for two years at a leading global mobile company.

Paul Canton

Vice President, Data Security and Cloud Technology, Chief of Staff

Living in Canada, Paul Canton is the VP of Data Security & Information Management for CSOFT International. Paul is responsible for working directly with IT, Management and Sales to support business development and client services.

Though he started in Political Science at Saint Mary’s University, in 2003 he made the move to the life science localization industry. Paul has more than 15 years of experience working in the translation and localization industry.

Carl Yao

Executive Vice President, Strategic Business Development & General Manager, Stepes

Bringing more than 15 years of experience to his role at CSOFT, Carl Yao is responsible for the strategic planning and business development of CSOFT’s services, products, and technologies across North America, Asia, and Europe.

With the goal of leveraging and expanding CSOFT’s globalization solutions portfolio to optimize business outcomes and help customers extract greater value from CSOFT’s offerings, Carl plays a key role in the formulation and execution of long-term strategies.Prior to CSOFT, Carl was the principal architect for the development of the world’s first multilingual speech engine that used natural human voice to synthesize speech at the company he founded, YAOS Technologies. He also served as the CTO for Animation Technologies, based in Boston, Massachusetts.

Carl has a Bachelor of Arts in Mathematics and Computer Science from Whitman College in Washington State and a Master’s degree in Computer Science from Brown University.

Vladimir (Vlado) Misik

VP Global Clinical Trial Strategy at CSOFT Health Sciences

Vladimir (Vlado) Misik brings more than 30 years of biomedical R&D experience into his role of VP Global Clinical Trial Strategy at CSOFT Health Sciences.

After his MSc degree physics and biophysics, and a PhD in biophysics and pharmacology, he worked as a several years as a research scientist in the fields of cardiology, at the School of Medicine at the George Washington University, and oncology, at the National Cancer Institute at the NIH in Bethesda. After his biomedical research scientist tenure, he moved into biopharma product development, including 15+ years at Quintiles/IQVIA in various senior executive roles including VP & Head of Central and Eastern Europe and MENA, and VP of Global Delivery Network. He also served as an executive board member and a CEO at SanaClis, a global full-service specialty CRO. He is a founder/ co-founder of two companies providing services to the clinical research industry: LongTaal, proprietary clinical trials informatics platform, and of VIARES, a clinical research talent organization.

Vlado in an author of > 60 research articles and book chapters in peer-reviewed journals: his current research focus are global geographic trends in industry clinical trials. He serves as an editorial board member at Applied Clinical Research, Clinical Trials, and Regulatory Affairs journal, and is a member of the DIA Core Committee for Clinical Research.